$0.0747
0.0091013.87%
At close: -
$0.0709
-0.00380-5.09%
After Hours: Dec 20, 7:49 PM EDT
Comments
Loading...
Conduit Pharmaceuticals (CDT) Forecast
NewsEarningsConduit Pharmaceuticals (CDT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestConduit Pharmaceuticals (NASDAQ:CDT) Stock Quotes, Forecast and News Summary
Conduit Pharmaceuticals Stock (NASDAQ: CDT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Conduit Pharmaceuticals (CDT) stock?
You can purchase shares of Conduit Pharmaceuticals (NASDAQ:CDT) through any online brokerage.
Who are Conduit Pharmaceuticals (CDT) competitors?
Other companies in Conduit Pharmaceuticals’s space includes: Harvard Bioscience (NASDAQ:HBIO), Quantum-Si (NASDAQ:QSI), Inotiv (NASDAQ:NOTV), Applied DNA Sciences (NASDAQ:APDN) and Lifecore Biomedical (NASDAQ:LFCR).
What is the forecast, or price target, for Conduit Pharmaceuticals (CDT) stock?
There is no analysis for Conduit Pharmaceuticals to provide a consensus price target.
What is the current price for Conduit Pharmaceuticals (CDT)?
The stock price for Conduit Pharmaceuticals (NASDAQ: CDT) is $0.0709 last updated December 20, 2024 at 7:49 PM EST.
Does Conduit Pharmaceuticals (CDT) pay a dividend?
There are no upcoming dividends for Conduit Pharmaceuticals.
When is Conduit Pharmaceuticals (NASDAQ:CDT) reporting earnings?
Conduit Pharmaceuticals’s Q4 earnings are confirmed for Friday, February 14, 2025.
Is Conduit Pharmaceuticals (CDT) going to split?
There is no upcoming split for Conduit Pharmaceuticals.
What sector and industry does Conduit Pharmaceuticals (CDT) operate in?
Conduit Pharmaceuticals is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.